Candriam S.C.A. Zimmer Biomet Holdings, Inc. Transaction History

Candriam S.C.A.

$16.9 Billion
Q4 2024

A detailed history of Candriam S.C.A. transactions in Zimmer Biomet Holdings, Inc. stock. As of the latest transaction made, Candriam S.C.A. holds 21,769 shares of ZBH stock, worth $2.28 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

21,769

Previous 17,433 24.87%

Holding current value

$2.28 Million

Previous $1.88 Million 22.22%

% of portfolio

0.01%

Previous 0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 06, 2025	BUY	$101.77 - $113.02 $441,274 - $490,054	4,336 Added 24.87%	21,769 $2.3 Million
Q3 2024 Nov 13, 2024	BUY	$104.47 - $116.17 $75,636 - $84,107	724 Added 4.33%	17,433 $1.88 Million
Q2 2024 Aug 05, 2024	SELL	$106.25 - $130.01 $3.53 Million - $4.33 Million	-33,269 Reduced 66.57%	16,709 $1.81 Million
Q1 2024 May 03, 2024	SELL	$119.98 - $132.61 $585,262 - $646,871	-4,878 Reduced 8.89%	49,978 $6.6 Million
Q4 2023 Feb 14, 2024	BUY	$102.72 - $121.7 $379,139 - $449,194	3,691 Added 7.21%	54,856 $6.68 Million
Q3 2023 Nov 13, 2023	BUY	$110.76 - $143.18 $945,225 - $1.22 Million	8,534 Added 20.02%	51,165 $5.74 Million
Q2 2023 Aug 08, 2023	SELL	$126.43 - $145.6 $3 Million - $3.45 Million	-23,708 Reduced 35.74%	42,631 $6.21 Million
Q1 2023 May 12, 2023	BUY	$121.91 - $130.94 $456,918 - $490,763	3,748 Added 5.99%	66,339 $8.57 Million
Q4 2022 Feb 13, 2023	SELL	$104.7 - $128.4 $1.68 Million - $2.06 Million	-16,047 Reduced 20.41%	62,591 $7.98 Million
Q3 2022 Nov 10, 2022	BUY	$101.65 - $119.27 $1.65 Million - $1.94 Million	16,268 Added 26.08%	78,638 $8.22 Million
Q2 2022 Aug 03, 2022	SELL	$102.23 - $133.85 $1.88 Million - $2.46 Million	-18,346 Reduced 22.73%	62,370 $6.55 Million
Q1 2022 May 13, 2022	SELL	$108.42 - $129.58 $23,960 - $28,637	-221 Reduced 0.27%	80,716 $10.3 Million
Q4 2021 Feb 10, 2022	BUY	$115.43 - $146.63 $1.14 Million - $1.44 Million	9,837 Added 13.84%	80,937 $10.3 Million
Q3 2021 Nov 09, 2021	SELL	$136.35 - $158.76 $12.2 Million - $14.3 Million	-89,771 Reduced 55.8%	71,100 $10.8 Million
Q2 2021 Jul 20, 2021	BUY	$152.95 - $173.41 $22.8 Million - $25.8 Million	149,029 Added 1258.48%	160,871 $26.6 Million
Q1 2021 Apr 29, 2021	BUY	$148.16 - $159.71 $1,333 - $1,437	9 Added 0.08%	11,842 $1.75 Million
Q4 2020 Jan 22, 2021	BUY	$128.25 - $151.41 $115,681 - $136,571	902 Added 8.25%	11,833 $1.82 Million
Q3 2020 Oct 19, 2020	BUY	$113.59 - $141.68 $133,809 - $166,899	1,178 Added 12.08%	10,931 $1.49 Million
Q2 2020 Jul 23, 2020	SELL	$87.02 - $133.4 $4.8 Million - $7.36 Million	-55,138 Reduced 84.97%	9,753 $1.16 Million
Q4 2019 Jan 21, 2020	SELL	$127.4 - $146.83 $1.7 Million - $1.95 Million	-13,308 Reduced 17.02%	64,891 $10,000
Q3 2019 Oct 21, 2019	SELL	$113.33 - $138.46 $9.54 Million - $11.6 Million	-84,139 Reduced 51.83%	78,199 $11,000
Q2 2019 Aug 01, 2019	BUY	$108.87 - $125.09 $5.54 Million - $6.36 Million	50,860 Added 45.62%	162,338 $19 Million
Q1 2019 May 02, 2019	BUY	$97.5 - $125.79 $1.47 Million - $1.89 Million	15,032 Added 15.59%	111,478 $14.2 Million
Q4 2018 Feb 14, 2019	BUY	$94.4 - $126.76 $4.5 Million - $6.04 Million	47,667 Added 97.72%	96,446 $10 Million
Q3 2018 Nov 07, 2018	SELL	$108.41 - $127.64 $7.39 Million - $8.7 Million	-68,199 Reduced 58.3%	48,779 $6.41 Million
Q2 2018 Aug 14, 2018	BUY	$102.12 - $114.04 $3.51 Million - $3.92 Million	34,332 Added 41.54%	116,978 $13 Million
Q1 2018 May 09, 2018	SELL	$104.31 - $124.46 $1.96 Million - $2.34 Million	-18,770 Reduced 18.51%	82,646 $9.01 Million
Q4 2017 Feb 07, 2018	BUY	$105.55 - $120.83 $986,364 - $1.13 Million	9,345 Added 10.15%	101,416 $12.2 Million
Q3 2017 Nov 03, 2017	BUY	$106.92 - $117.79 $9.84 Million - $10.8 Million	92,071	92,071 $10.8 Million

Others Institutions Holding ZBH

# of Institutions

1,127

Shares Held

181M

Call Options Held

450K

Put Options Held

619K

View Full List

About ZIMMER BIOMET HOLDINGS, INC.

Ticker ZBH
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 209,820,000
Market Cap $22B
Description
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, bi...

More about ZBH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.

Account